Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion type Assertion NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_head.
- NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion description "[The MxA promoter with haplotype -88T/-123A confers greater expression of MxA in vitro, as well as a better treatment outcome for chronic hepatitis C patients treated with interferon in vivo, as compared to the MxA promoter with haplotype -88G/-123C.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_provenance.
- NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion evidence source_evidence_literature NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_provenance.
- NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion SIO_000772 11805446 NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_provenance.
- NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion wasDerivedFrom lhgdn-20090331 NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_provenance.
- NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_assertion wasGeneratedBy ECO_0000203 NP193015.RA_6TEJtZhS2SrWbdY4lGkmiOwcYYvd9Fh86MUNE1xxoA130_provenance.